openPR Logo
Press release

Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.

04-11-2022 02:11 PM CET | Health & Medicine

Press release from: SMi Group

P-376 PR4

P-376 PR4

Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.

With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading pharmaceutical and biotechnology companies.

Register your place online at:

SMi caught up with Ester Lovsin Barle, Head of Product Stewardship and Health, Takeda Pharmaceutical Company Ltd to discuss her role, priorities, current projects, opportunities, and her involvement as a speaker at the upcoming event.

Considering Highly Potent APIs continues to be an important aspect of pharmaceutical manufacturing, have you seen any changes toward their handling or discussion in the past year?

Health and safety of the employees are still a top priority for our company. On a corporate side we strive to develop and integrate management systems to site operations, especially those that handle compounds that may pose higher risks due to their intrinsic hazards. While there have been many discussions during the COVID-19 pandemic about the relevance of risk vs hazards, the difference is still a challenge to communicate.

What is the greatest challenge for you to personally overcome within the Highly Potent API field currently?

There has been a shift in operations to include new technologies and utilize old technologies in more sustainable manner. At Takeda we strive to be a leader in sustainability. The combination of sustainability thinking, and health protection needs experts from both sides to have a join conversation, not to shift any risks in the value chain. An example about these synergies was published by Schmidt and Guytingco recently in an article titled Ventilation and Sustainable Laboratories (

What topic will you be addressing in your presentation and what would you say will make it relevant to the audience in 2022?

The topic of safe limits is increasingly reaching the awareness of us all. We know about our planetary limits, and equally we have limits for the chemicals that we are exposed to. I will talk about these limits.

Ester will be presenting on day one of the conference on "Hazards and Potency of New Therapeutic Modalities" which covers:
•Assessment of data relevancy, adequacy, reliability
•Determination of exposure limits in the absence of data
•Case study of nucleic acids

Download the brochure at:

SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to compliment you company's marketing strategy, For more details and all delegate enquiries please contact Luke Teachen on +44 (0) 20 7827 6002 or

SMi's 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference
Conference: 9th - 10th May 2022
Interactive Workshops: 11th May 2022
London, UK

India House, 45 Curlew Street

--- ENDS -

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference. here

News-ID: 2599906 • Views: 615

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The
Assessing device development and regulation for advanced innovation
Assessing device development and regulation for advanced innovation
Pre Filled Syringes West Coast USA Conference 2022 Launches Assessing device development and regulation for advanced innovation SMi's 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi's leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly

All 5 Releases

More Releases for Highly

Desalination of highly concentrated salt water
A new process for the purification of very highly contaminated saline water, which often occurs in the Middle East and the Gulf States. Drinking water is an increasingly scarce resource in many parts of the world. The standard technology for desalinating seawater is reverse osmosis (RO). This technology works, but it is very complex and too expensive. It cannot be used with high salt contents. That's why we thought about it
Empress Idama Releases Highly Anticipated Single
Accomplished Singer and African Dancer Creates Buzz in Europe They say that it’s all in a name. With a name as powerful as I Empress Idama, Idama was more than ready to unleash her interwomen sound of Traditional West African, reggae, and jazz on her highly anticipated new single, “Jah Rastafar”. Though originally from Ethiopia, Idama has roots in Jamaica and the USA. She attributes her outstanding
Highly affecting Bugs of 2017
In 2017, nearly half of the total populace confronted various bug in software testing, as indicated by a software product testing organization TestOrigen. Simply envision, 2017 bug issues influenced approx 75,000 passengers. Is it happen? It is known as software “butterfly impact” – “little variety in the underlying states of a dynamic framework may deliver vast variety in the long haul conduct of the framework”. As indicated by the TestOrigen’ “One glitch
Allantoin Industry Highly Growth And Demand
Sample PDf Available Here !! The 'Global and Chinese Allantoin Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Allantoin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Allantoin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Report Details
"Sherwood" - Highly Regarded Monaro District Property
Over 80 Years Ownership Large Scale & Versatile Sheep and Cattle Breeding Enterprise Comprising Alluvial River Flats & Fertile Basalt Grazing Country Approx. 6.5km MacLaughlin River Frontage Approx. 3,682.89 ha – 9,100 acres (freehold) Approx. 1,189.26ha – 2,939 acres (available for lease) - Well located - 55km south of Cooma, 175km Canberra, approx. 1 ½ hours South Coast beaches & 1 ¼ hours snowfields - Excellent balance of country - ranging from alluvial
Containment for highly potent APIs
This year the GEA Pharma Systems stand at ACHEMA will include the company’s wide range of specialist equipment for processing highly potent compounds providing the highest yields and levels of operator and environmental protection available. Courtoy™ MODUL™ tablet press Centre stage on the stand will be the unique Courtoy™ MODUL™ tablet press with its Exchange Compression Module (ECM) that contains all the product-contact components within a sealed central core that can be